Stock Events

Stock Events

NeOnc Technologies 

$3,27
3
+$0,41+14,34%Pazartesi 03:30

İstatistikler

Günün en yüksek
3,27
Günlük en düşük
3,27
52H Zirve
5,52
52H Dip
2,53
Hacim
-
Ort. Hacim
-
Piyasa değeri
94,19M
F/K Oranı
-
Temettü verimi
-
Temettü
-

Yaklaşan

Finansal sonuçlar

13 KasBeklenen
Q3 2025
Q1 2026
Q2 2026
Sonraki
-0,58
-0,43
-0,27
-0,12
Beklenen EPS
-0,24804
Gerçekleşen EPS
Yok

Finansallar

-155.365%Kâr marjı
Kârsız
2021
2022
2023
2024
2025
40.000Gelir
-62,15MNet kâr

Analist değerlendirmeleri

$17,00Ortalama fiyat hedefi
En yüksek tahmin ⁦20,00⁩.
Son 6 ay içindeki 4 değerlendirmeden. Bu bir yatırım tavsiyesi değildir.
Al
100%
Tut
0%
Sat
0%

Rakipler

Bu liste, son piyasa olaylarına dayalı bir analizdir. Yatırım tavsiyesi değildir.

Hakkında

NeOnc Technologies Holdings Inc., merkezi sinir sistemi hastalıklarını tedavi etmek amacıyla terapötiklerin hedeflenmiş teslimatı için yeni moleküler teknolojiler geliştirmeye odaklanmış, klinik aşamadaki bir biyofarmasötik şirketidir. Şirket; gliom, glioblastoma ve meningiom gibi kafa içi maligniteler için ilaç iletim yöntemleri ve ilaç adayları geliştirmektedir. Öncü ürün adayları arasında, beyin kanseri hastaları için intranazal bir ilaç iletim tedavisi olan NEO100 ve glioblastoma tedavisini geliştirmek üzere tasarlanmış oral bir kimyasal konjugat olan NEO212 yer almaktadır.
Daha fazla göster
CEO
ISIN
US64051A1016

Kotasyonlar

XNAS
US
NTHI
BOATS
BOATS
NTHI.BOATS

0 yorum

Düşüncelerini paylaş

SSS

NeOnc Technologies hissesinin bugünkü fiyatı nedir?▼
NTHI.BOATS’un güncel fiyatı $3,27 USD — son 24 saatte %+14,34% arttı. NeOnc Technologies hissesinin fiyat performansını grafikte daha yakından izle.
NeOnc Technologies hissesinin sembolü nedir?▼
Borsaya bağlı olarak hisse sembolü değişebilir. Örneğin, Boats borsasında NeOnc Technologies hisseleri NTHI.BOATS sembolüyle işlem görür.
NeOnc Technologies’in piyasa değeri nedir?▼
Bugün NeOnc Technologies’in piyasa değeri 94,19M
NeOnc Technologies bir sonraki finansal sonuçlarını ne zaman açıklayacak?▼
NeOnc Technologies, bir sonraki finansal raporunu 13 Kasım 2026 tarihinde açıklayacak.
NeOnc Technologies’in geçen çeyrekteki finansal sonuçları nasıldı?▼
NTHI.BOATS’in son çeyrek finansal sonuçları hisse başına -0,58 USD oldu, tahmin ise -0,12 USD idi ve -397,14%’lik bir sürpriz oluştu. Gelecek çeyrek için tahmini sonuçlar hisse başına Yok USD olarak bekleniyor.
NeOnc Technologies’in geçen yılki geliri ne kadardı?▼
NeOnc Technologies’in geçen yılki geliri 40.000 USD tutarındadır.
NeOnc Technologies’in geçen yılki net geliri neydi?▼
NTHI.BOATS’in geçen yılki net geliri -62,15M USD.
NeOnc Technologies hangi sektörde yer alıyor?▼
NeOnc Technologies, Diğer sektöründe faaliyet göstermektedir.
NeOnc Technologies hisse bölünmesini ne zaman tamamladı?▼
NeOnc Technologies son zamanlarda herhangi bir split gerçekleştirmedi.
dan işlem görüyor.","summary":"","url":"https://247wallst.com/investing/2026/05/14/forget-the-242-biotech-meme-this-brain-cancer-stock-has-a-38-analyst-target-and-trades-at-6/","imageUrl":"https://assets.stockevents.app/images/xl/ad1dad9a-1dc5-4fc6-b893-9af1e4393d7a.webp","sentiment":"","type":"Article","sourceName":"24/7 Wall St.","topics":[]},{"id":61440672,"symbols":["ACXP","CAST","DVLT","IGC","MDCX","MDCXW","NTHI","VTIX","VVOS","YYGH"],"date":"2026-04-18T14:00:00Z","title":"The Street'in yeni bölümü bu akşam EST saatiyle 18:30'da Bloomberg'de yayında! 744. bölümde Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH) ve Vivos Therapeutics (NASDAQ:VVOS) konuk oluyor.","summary":"","url":"https://finance.yahoo.com/markets/stocks/articles/street-broadcast-tonight-bloomberg-6-140000014.html","imageUrl":"","sentiment":"","type":"Article","sourceName":"ACCESS Newswire","topics":[]},{"id":61385908,"symbols":["NTHI"],"date":"2026-04-01T13:00:00Z","title":"NeOnc Provides Business Update and Reports Q4 2025 Financial Results","summary":"","url":"https://finance.yahoo.com/sectors/healthcare/articles/neonc-provides-business-reports-q4-130000601.html","imageUrl":"https://assets.stockevents.app/images/xl/a16c223d-0559-4d07-927e-cf26bc5948c7.webp","sentiment":"","type":"Article","sourceName":"GlobeNewswire","topics":[]},{"id":61309422,"symbols":["NTHI"],"date":"2026-03-13T13:00:00Z","title":"NeOnc Technologies Appoints David Choi as Chief Accounting Officer","summary":"","url":"https://finance.yahoo.com/news/neonc-technologies-appoints-david-choi-130000426.html","imageUrl":"https://assets.stockevents.app/images/xl/7ec24b71-fa16-467c-8267-556fccc5f05e.webp","sentiment":"","type":"Article","sourceName":"GlobeNewswire","topics":[]},{"id":61303848,"symbols":["NTHI"],"date":"2026-03-12T12:52:00Z","title":"Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)","summary":"","url":"https://finance.yahoo.com/news/stonegate-capital-partners-updates-coverage-125200544.html","imageUrl":"https://assets.stockevents.app/images/xl/9a1e04f9-6c50-4ccc-8b45-68d268747ea3.webp","sentiment":"","type":"Article","sourceName":"TMX Newsfile","topics":[]},{"id":61266771,"symbols":["NTHI"],"date":"2026-03-04T13:00:00Z","title":"NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET","summary":"","url":"https://finance.yahoo.com/news/neonc-technologies-reports-phase-1-130000521.html","imageUrl":"https://assets.stockevents.app/images/xl/a6f740c0-2400-468e-bef3-9c201da2af93.webp","sentiment":"","type":"Article","sourceName":"GlobeNewswire","topics":[]},{"id":61245821,"symbols":["NTHI"],"date":"2026-02-27T14:00:00Z","title":"NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity","summary":"","url":"https://finance.yahoo.com/news/neonc-technologies-nasdaq-nthi-host-140000402.html","imageUrl":"https://assets.stockevents.app/images/xl/85c462d1-7e0b-4b71-8838-f4077883b617.webp","sentiment":"","type":"Article","sourceName":"GlobeNewswire","topics":[]},{"id":61215590,"symbols":["BIVI","BIVIW","NTHI","PETV","SGTM","SNYR","VTIX","VVOS","YYGH"],"date":"2026-02-21T15:45:00Z","title":"New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America","summary":"","url":"https://finance.yahoo.com/news/street-broadcast-executive-leadership-interviews-154500997.html","imageUrl":"","sentiment":"","type":"Article","sourceName":"ACCESS Newswire","topics":[]},{"id":61186669,"symbols":["AERT","NTHI","PETV","SDST","SNYR","VTIX","VVOS","YYGH"],"date":"2026-02-14T15:10:00Z","title":"New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST)","summary":"","url":"https://finance.yahoo.com/news/street-broadcast-show-726-bloomberg-151000205.html","imageUrl":"","sentiment":"","type":"Article","sourceName":"ACCESS Newswire","topics":[]},{"id":61153134,"symbols":["ATON","DVLT","NTHI","PETV","RDZN","SNYR","VTIX","YYGH"],"date":"2026-02-07T17:55:00Z","title":"New to The Street(R) Airs Tonight on Bloomberg Television Across the U.S., MENA & Latin America","summary":"","url":"https://finance.yahoo.com/news/street-r-airs-tonight-bloomberg-175500986.html","imageUrl":"","sentiment":"","type":"Article","sourceName":"ACCESS Newswire","topics":[]},{"id":61119240,"symbols":["ATON","DVLT","FEED","NAOV","NTHI","PETV","SGTM","SNYR"],"date":"2026-01-31T15:00:00Z","title":"New to The Street Broadcasts Today on Bloomberg Across the U.S., MENA, and Latin America","summary":"","url":"https://finance.yahoo.com/news/street-broadcasts-today-bloomberg-across-150000693.html","imageUrl":"","sentiment":"","type":"Article","sourceName":"ACCESS Newswire","topics":[]},{"id":61115759,"symbols":["NTHI"],"date":"2026-01-30T14:00:00Z","title":"NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management","summary":"","url":"https://finance.yahoo.com/news/neonc-technologies-secures-strategic-pipe-140000004.html","imageUrl":"https://assets.stockevents.app/images/xl/40cdc374-cbab-4fce-98ee-8d7e15023544.webp","sentiment":"","type":"Article","sourceName":"GlobeNewswire","topics":[]},{"id":61019840,"symbols":["NTHI"],"date":"2026-01-10T00:32:00Z","title":"Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)","summary":"","url":"https://finance.yahoo.com/news/stonegate-capital-partners-initiates-coverage-003200149.html","imageUrl":"https://assets.stockevents.app/images/xl/b5a34363-31ff-4faf-8de1-2a8ea8a3c71b.webp","sentiment":"","type":"Article","sourceName":"TMX Newsfile","topics":[]},{"id":60990587,"symbols":["DVLT","NTHI","SAGT","SGTM","SNYR"],"date":"2026-01-03T17:10:00Z","title":"New to The Street Airs Tonight on Bloomberg Television - Show No. 712 Sponsored Programming Spotlighting Public and Private Market Innovators","summary":"","url":"https://finance.yahoo.com/news/street-airs-tonight-bloomberg-television-171000931.html","imageUrl":"","sentiment":"","type":"Article","sourceName":"ACCESS Newswire","topics":[]},{"id":60975097,"symbols":["DVLT","LTRN","NTHI","PETV","SGTM","SNYR"],"date":"2025-12-27T22:00:00Z","title":"New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television","summary":"","url":"https://finance.yahoo.com/news/street-show-710-airs-tonight-220000755.html","imageUrl":"","sentiment":"","type":"Article","sourceName":"ACCESS Newswire","topics":[]},{"id":60957625,"symbols":["ACXP","AERT","CISO","DVLT","NRXP","NTHI","PETV","SGTM","SNYR"],"date":"2025-12-20T23:15:00Z","title":"New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP)","summary":"","url":"https://finance.yahoo.com/news/street-broadcasts-nationwide-tonight-bloomberg-231500539.html","imageUrl":"","sentiment":"","type":"Article","sourceName":"ACCESS Newswire","topics":[]},{"id":60931320,"symbols":["NTHI"],"date":"2025-12-15T14:00:00Z","title":"NeOnc Technologies Reports Updated Clinical Results","summary":"","url":"https://finance.yahoo.com/news/neonc-technologies-reports-updated-clinical-140000614.html","imageUrl":"https://assets.stockevents.app/images/xl/14e0028d-4120-47a8-84f9-f568feaf0804.webp","sentiment":"","type":"Article","sourceName":"GlobeNewswire","topics":[]},{"id":60873718,"symbols":["NTHI"],"date":"2025-12-02T13:03:01Z","title":"Insider Buys Additional US$185k In NeOnc Technologies Holdings Stock","summary":"","url":"https://finance.yahoo.com/news/insider-buys-additional-us-185k-130301856.html","imageUrl":"https://assets.stockevents.app/images/xl/28053094-e04c-4b5a-ad33-d52718e4e4eb.webp","sentiment":"","type":"Article","sourceName":"Simply Wall St.","topics":[]},{"id":60868529,"symbols":["NTHI"],"date":"2025-12-01T14:00:00Z","title":"NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors","summary":"","url":"https://finance.yahoo.com/news/neonc-technologies-nasdaq-nthi-announces-140000206.html","imageUrl":"https://assets.stockevents.app/images/xl/a1587ab2-198f-4fcf-8371-d8b0eec13555.webp","sentiment":"","type":"Article","sourceName":"GlobeNewswire","topics":[]},{"id":60802240,"symbols":["NTHI"],"date":"2025-11-14T21:01:00Z","title":"NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update","summary":"","url":"https://finance.yahoo.com/news/neonc-technologies-holdings-reports-third-210100718.html","imageUrl":"https://assets.stockevents.app/images/xl/9a07c406-1d92-4500-87e1-4c6b91e12d97.webp","sentiment":"","type":"Article","sourceName":"GlobeNewswire","topics":[]},{"id":60799554,"symbols":["NTHI"],"date":"2025-11-14T11:17:36Z","title":"With 61% ownership, NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) insiders have a lot riding on the company's future","summary":"","url":"https://finance.yahoo.com/news/61-ownership-neonc-technologies-holdings-111736224.html","imageUrl":"https://assets.stockevents.app/images/xl/69f2bbc1-f8f7-45c7-9339-2f9a9faef922.webp","sentiment":"","type":"Article","sourceName":"Simply Wall St.","topics":[]},{"id":60794011,"symbols":["NTHI"],"date":"2025-11-13T14:00:00Z","title":"NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High‑Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026)","summary":"","url":"https://finance.yahoo.com/news/neonc-technologies-completes-enrollment-pivotal-140000496.html","imageUrl":"https://assets.stockevents.app/images/xl/45096de7-a7af-447a-9baa-99096dd63d1a.webp","sentiment":"","type":"Article","sourceName":"GlobeNewswire","topics":[]},{"id":60785830,"symbols":["NTHI"],"date":"2025-11-12T13:00:00Z","title":"NeOnc Technologies Reports Updated Clinical Results","summary":"","url":"https://finance.yahoo.com/news/neonc-technologies-reports-updated-clinical-130000491.html","imageUrl":"https://assets.stockevents.app/images/xl/60c73545-8ef5-4bed-b95b-810405ea142a.webp","sentiment":"","type":"Article","sourceName":"GlobeNewswire","topics":[]},{"id":60763258,"symbols":["NTHI"],"date":"2025-11-07T14:00:00Z","title":"NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program","summary":"","url":"https://finance.yahoo.com/news/neonc-technologies-nasdaq-nthi-host-140000182.html","imageUrl":"https://assets.stockevents.app/images/xl/8138d37c-0255-4890-a922-68e2e843686a.webp","sentiment":"","type":"Article","sourceName":"GlobeNewswire","topics":[]},{"id":60738781,"symbols":["NTHI"],"date":"2025-11-04T14:00:00Z","title":"NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth","summary":"","url":"https://finance.yahoo.com/news/neonc-technologies-appoints-amir-heshmatpour-140000436.html","imageUrl":"https://assets.stockevents.app/images/xl/b20243c0-2032-4fbf-9bb6-59fdf88e0cb1.webp","sentiment":"","type":"Article","sourceName":"GlobeNewswire","topics":[]}]},"requestCountry":""}; window.anonymousUserId = 'be640db0-bece-11ea-dbe5-7da5f4bf85d3'; window.refreshToken = 'eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJleHAiOjQ5NDcxOTA5MDQsInJlZnJlc2hfdXVpZCI6IjQwNzRlMjQ1LWE0ODYtNGYyMy05MmM0LWVmNTMzNDdiOGYwMSsrYmU2NDBkYjAtYmVjZS0xMWVhLWRiZTUtN2RhNWY0YmY4NWQzIiwidXNlcl9pZCI6ImJlNjQwZGIwLWJlY2UtMTFlYS1kYmU1LTdkYTVmNGJmODVkMyJ9.bLNxyIB1rYzQ-yAz1VHAQ9UY-hnn5nIYOgjJz5dZFxI'; window.accessToken = 'eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJhY2Nlc3NfdXVpZCI6IjQwNzRlMjQ1LWE0ODYtNGYyMy05MmM0LWVmNTMzNDdiOGYwMSIsImF1dGhvcml6ZWQiOnRydWUsImV4cCI6MTc5MzU5NDUwNCwidXNlcl9pZCI6ImJlNjQwZGIwLWJlY2UtMTFlYS1kYmU1LTdkYTVmNGJmODVkMyJ9.cG9JuqvRo751igt-uWsC61lQ1TO-6iRSGzgPF5iczNY'; window.isBot = true; window.apiUrl = '/api/'; window.cloudflareTurnstileSiteKey = "0x4AAAAAADNJpCHEAHWMSwjy"; window.abVariants = {"home":"v6","dividends":"v4"}; window.staticData = {"countryOptions":null,"homeHeroVideo":null};
Stock Events

Stock Events

NeOnc Technologies 

$3,27
3
+$0,41+14,34%Pazartesi 03:30

İstatistikler

Günün en yüksek
3,27
Günlük en düşük
3,27
52H Zirve
5,52
52H Dip
2,53
Hacim
-
Ort. Hacim
-
Piyasa değeri
94,19M
F/K Oranı
-
Temettü verimi
-
Temettü
-

Yaklaşan

Finansal sonuçlar

13 KasBeklenen
Q3 2025
Q1 2026
Q2 2026
Sonraki
-0,58
-0,43
-0,27
-0,12
Beklenen EPS
-0,24804
Gerçekleşen EPS
Yok

Finansallar

-155.365%Kâr marjı
Kârsız
2021
2022
2023
2024
2025
40.000Gelir
-62,15MNet kâr

Analist değerlendirmeleri

$17,00Ortalama fiyat hedefi
En yüksek tahmin ⁦20,00⁩.
Son 6 ay içindeki 4 değerlendirmeden. Bu bir yatırım tavsiyesi değildir.
Al
100%
Tut
0%
Sat
0%

Rakipler

Bu liste, son piyasa olaylarına dayalı bir analizdir. Yatırım tavsiyesi değildir.

Hakkında

NeOnc Technologies Holdings Inc., merkezi sinir sistemi hastalıklarını tedavi etmek amacıyla terapötiklerin hedeflenmiş teslimatı için yeni moleküler teknolojiler geliştirmeye odaklanmış, klinik aşamadaki bir biyofarmasötik şirketidir. Şirket; gliom, glioblastoma ve meningiom gibi kafa içi maligniteler için ilaç iletim yöntemleri ve ilaç adayları geliştirmektedir. Öncü ürün adayları arasında, beyin kanseri hastaları için intranazal bir ilaç iletim tedavisi olan NEO100 ve glioblastoma tedavisini geliştirmek üzere tasarlanmış oral bir kimyasal konjugat olan NEO212 yer almaktadır.
Daha fazla göster
CEO
ISIN
US64051A1016

Kotasyonlar

XNAS
US
NTHI
BOATS
BOATS
NTHI.BOATS

0 yorum

Düşüncelerini paylaş

SSS

NeOnc Technologies hissesinin bugünkü fiyatı nedir?▼
NTHI.BOATS’un güncel fiyatı $3,27 USD — son 24 saatte %+14,34% arttı. NeOnc Technologies hissesinin fiyat performansını grafikte daha yakından izle.
NeOnc Technologies hissesinin sembolü nedir?▼
Borsaya bağlı olarak hisse sembolü değişebilir. Örneğin, Boats borsasında NeOnc Technologies hisseleri NTHI.BOATS sembolüyle işlem görür.
NeOnc Technologies’in piyasa değeri nedir?▼
Bugün NeOnc Technologies’in piyasa değeri 94,19M
NeOnc Technologies bir sonraki finansal sonuçlarını ne zaman açıklayacak?▼
NeOnc Technologies, bir sonraki finansal raporunu 13 Kasım 2026 tarihinde açıklayacak.
NeOnc Technologies’in geçen çeyrekteki finansal sonuçları nasıldı?▼
NTHI.BOATS’in son çeyrek finansal sonuçları hisse başına -0,58 USD oldu, tahmin ise -0,12 USD idi ve -397,14%’lik bir sürpriz oluştu. Gelecek çeyrek için tahmini sonuçlar hisse başına Yok USD olarak bekleniyor.
NeOnc Technologies’in geçen yılki geliri ne kadardı?▼
NeOnc Technologies’in geçen yılki geliri 40.000 USD tutarındadır.
NeOnc Technologies’in geçen yılki net geliri neydi?▼
NTHI.BOATS’in geçen yılki net geliri -62,15M USD.
NeOnc Technologies hangi sektörde yer alıyor?▼
NeOnc Technologies, Diğer sektöründe faaliyet göstermektedir.
NeOnc Technologies hisse bölünmesini ne zaman tamamladı?▼
NeOnc Technologies son zamanlarda herhangi bir split gerçekleştirmedi.